Assessing Strategies to Mitigate the Effect of Age When Using FIB-4 Index to Screen for MASLD-Related Liver Fibrosis

More on Metabolic dysfunction-associated steatotic liver disease

• NMR metabolomics improves prediction of cardiometabolic diseases

  medRxiv · 4 Oct 2026

  

• Dasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial

  Nature Metabolism · 2 Oct 2026

• Cardiometabolic burden is linked to CVD and death in MASLD

  Frontiers in Nutrition · 4 Oct 2026

  

• Alternate-day fasting curbs liver fibrosis in mice

  Advanced Science · 2 Oct 2026